Kontro Lab
@LabKontro
Followers
78
Following
65
Media
4
Statuses
12
Novel treatments for acute myeloid leukemia #FIMM_UH
Helsinki, Finland
Joined October 2021
RT @BasClinPharmTox: 1/4. Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multic….
0
1
0
Ex vivo venetoclax sensitivity identified treatment responders and correlated with improved outcomes and prolonged survival. Groundbreaking results from the VenEx trial with the Finnish AML Group, @helsinkiuni and @FIMM_UH published now in @BloodJournal.
VenEx trial showed that ex vivo drug sensitivity is beneficial for selecting patients with R/R or sAML for venetoclax-azacitidine therapy. #clinicaltrialsandobservations #myeloidneoplasia
2
2
13
RT @FIMM_UH: Drug sensitivity testing on leukemia cells can predict how patients with acute myeloid leukemia (AML) will respond to a new co….
0
2
0
RT @FIMM_UH: Leukemiasolujen lääkeherkkyystestauksella voidaan ennustaa akuuttia myelooista leukemiaa sairastavien potilaiden hoitovaste u….
0
2
0
Dr. Mika Kontro from @KontroLab discussed the latest advances in functional screening during the Multi-Omics Driven Precision Hematology Scientific Symposia at #ASH23. The VenEx trial indicates the efficacy of ex vivo venetoclax testing for predicting VEN+AZA responses in AML.
0
6
27
RT @CancerInstFIN: Meet our K. Albin Johansson Cancer Researcher @hkuusanm. Heikki has a versatile background in translational laboratory s….
syopainstituutti.com
Researcher of the Month is a series started in January 2023 where FCI's researchers are introduced.
0
3
0
RT @FIMM_UH: A clinical trial performed in Finland has shown that a drug sensitivity test performed on patient's own cells in laboratory co….
helsinki.fi
A clinical trial performed in Finland has shown that a drug sensitivity test performed on patient's own cells in laboratory conditions predicts patient's response to a new effective leukemia drug,...
0
1
0
RT @hkuusanm: 1/ Excited to share our study with @ollidufva suggesting venetoclax resistance and BCL-XL dependence in erythroid/megakaryobl….
0
20
0
Our newest paper "Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia" is now published and accessible @Haematologica .
0
2
14
RT @ollidufva: Ex vivo venetoclax sensitivity predicts responses in both de novo and s/R/R AML patients @LabKontro #ASH22 .
0
2
0
Excellent talk by @josephsaad95 on NAMPT inhibitors in AML with monosomy 7/del(7q) yesterday at #ASH22!
0
1
6
Ex vivo drug sensitivity testing predicts venetoclax+azacitidine treatment responses in AML. VenEx trial interim results presented at #ASH21
0
6
21